Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci

被引:18
|
作者
Davis, John W. [1 ]
Kim, Jeri [4 ]
Ward, John F.
Wang, Xuemai [3 ]
Nakanishi, Hiro
Babaian, R. Joseph
Troncoso, Patricia [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 1373, Dept Urol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
关键词
prostate cancer; active surveillance; radical prostatectomy; ACTIVE SURVEILLANCE; SELECTING PATIENTS; MEN; FEATURES; ADENOCARCINOMA; VALIDATION; CANDIDATES; MANAGEMENT; NOMOGRAM; UPDATE;
D O I
10.1111/j.1464-410X.2009.08964.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To measure total tumour volume (TTV) and dominant TV (DTV) in radical prostatectomy (RP) specimens from patients predicted to have low-volume, low-grade (LV/LG) prostate cancer, as this entity can be predicted from biopsy findings and prostate-specific antigen (PSA) level, but tumour under-sampling remains a challenge in active surveillance programmes. PATIENTS AND METHODS This was a retrospective study from an academic centre, of men with prostate cancer treated from 2000 to 2007, with a PSA level of < 10 ng/mL and one core of cancer from an extended scheme showing either Gleason score (GS) 3 + 3 of < 3.0 mm or 3 + 4 of < 2.0 mm. All men had RP, and the TTV, DTV, tumour location, pathological GS and stage were measured. RESULTS Of 3055 RPs, 66 (2.1%) met the inclusion criteria. The core with cancer was from a sextant and alternative site in 26 (39%) and 40 (61%) patients, respectively. A pathological GS 3 + 3 or 3 + 4 was assigned to 94%, while 6% were GS >= 4 + 3; all 66 tumours were organ-confined. The median (range) TTV and DTV were 0.15 (0.0008-5.06) and 0.14 (0.0008-5.04) mL, respectively. The median number of tumour foci was 3 (1-7), being unifocal in 17/66 (26%) and multifocal in 49/66 (74%). The transition zone was involved in 29% of unifocal and 71% of multifocal tumours. Of all 66 patients, the TTV was < 0.5 mL in 47 (71%), and of 59 patients with biopsy GS 3 + 3, 33 (56%) had a TTV of < 0.5 mL and pathological GS 3 + 3. Of 19 patients with a TTV of >= 0.5 mL, the median TTV was 1.06 (0.51-5.05) mL, with tumour foci of transition zone origin in 16 (84%). The study was limited by its retrospective design and small sample size. CONCLUSIONS Using conservative selection criteria for predicting LV/LG cancer, RP specimens showed organ-confined disease in all cases, upgrading to GS >= 4 + 3 in 6%, and TTV < 0.5 mL in 71% of cases. The transition zone is a common location of under-sampled disease.
引用
收藏
页码:1386 / 1391
页数:6
相关论文
共 7 条
  • [1] Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis
    Bjorklund, Johan
    Cheung, Douglas C. C.
    Martin, Lisa J. J.
    Komisarenko, Maria
    Lajkosz, Katharine
    Hamilton, Robert J. J.
    Zlotta, Alexandre R. R.
    Finelli, Antonio
    SCANDINAVIAN JOURNAL OF UROLOGY, 2023, 57 (1-6) : 29 - 35
  • [2] 'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?
    Trpkov, Kiril
    Yilmaz, Asli
    Bismar, Tarek A.
    Montironi, Rodolfo
    BJU INTERNATIONAL, 2010, 106 (03) : 304 - 315
  • [3] A nomogram for predicting low-volume/low-grade prostate cancer - A tool in selecting patients for active surveillance
    Nakanishi, Hiroyuki
    Wang, Xuemei
    Ochiai, Atsushi
    Trpkov, Kiril
    Yilmaz, Asli
    Donnelly, J. Bryan
    Davis, John W.
    Troncoso, Patricia
    Babaian, R. Joseph
    CANCER, 2007, 110 (11) : 2441 - 2447
  • [4] Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy
    Gallina, Andrea
    Maccagnano, Carmen
    Suardi, Nazareno
    Capitanio, Umberto
    Abdollah, Firas
    Raber, Marco
    Salonia, Andrea
    Scattoni, Vincenzo
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    BJU INTERNATIONAL, 2012, 110 (2B) : E64 - E68
  • [5] The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
    Lumen, Nicolaas
    De Bleser, Elise
    Buelens, Sarah
    Verla, Wesley
    Poelaert, Filip
    Claeys, Wietse
    Fonteyne, Valerie
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Van Praet, Charles
    Decaestecker, Karel
    Ost, Piet
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 29 : 68 - 76
  • [6] Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
    Zellweger, Tobias
    Guenther, Sarah
    Zlobec, Inti
    Savic, Spasenija
    Sauter, Guido
    Moch, Holger
    Mattarelli, Gianfranco
    Eichenberger, Tobias
    Curschellas, Enrico
    Ruefenacht, Hansjoerg
    Bachmann, Alexander
    Gasser, Thomas C.
    Mihatsch, Michael J.
    Bubendorf, Lukas
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (09) : 2116 - 2123
  • [7] Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
    Fan, Junjie
    Xu, Ke
    Jiang, Zhangdong
    Gan, Chaosheng
    Song, Hao
    Gao, Guoqiang
    Wang, Guojing
    Kang, Qiyuan
    Luo, Liang
    Wang, Zhuonan
    He, Dalin
    Duan, Xiaoyi
    Wu, Kaijie
    BMC CANCER, 2025, 25 (01)